Movano Inc 2025年季度报告

FORM10-Q (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDEDJUNE 30,2025 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER:001-40254 MOVANO INC.(Exact name of registrant as specified in its charter) (415)651-3172(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on whichregistered Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d)of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2)has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smallerreporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company” and “emerging growth company” in Rule12b-2 of the Exchange Act: If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act). Yes☐No☒ As of September 22, 2025, there were8,349,080shares of our common stock, par value $0.0001 per share, outstanding. MOVANO INC.FORM 10-QFOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025 INDEX PAGEPART I – FINANCIAL INFORMATION1Item 1. Financial Statements1Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations20Item 3. Quantitative and Qualitative Disclosure About Market Risk28Item 4. Controls and Procedures28PART II – OTHER INFORMATION29Item 1. Legal Proceedings29Item 1A. Risk Factors29Item 2. Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities30Item 3. Defaults Upon Senior Securities30Item 4. Mine Safety Disclosures30Item 5. Other Information30Item 6. Exhibits31SIGNATURES32EXHIBIT INDEX PART I – FINANCIAL INFORMATION Movano Inc.Condensed Consolidated Balance Sheets(in thousands, except share and per share data)(Unaudited) LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent liabilities: Stockholders’ equity:Preferred stock, $0.0001par value,5,000,000shares authorized at June 30, 2025 and December 31,2024;noshares issued and outstanding at June 30, 2025 and December 31, 2024——Common stock, $0.0001par value,500,000,000shares authorized at June 30, 2025 and December31, 2024;8,301,204and6,840,291shares issued and outstanding at June 30, 2025 and December31, 2024, respectively1010Additional paid-in capital158,137155,452Accumulated deficit(156,510)(148,107)Total stockholders’ equity1,6377,355Total liabilities and stockholders’ equity$5,660$11,320 Movano Inc.Condensed Consolidated Statements of Operations and Comprehensive Loss(in thousands, except share and per share data)(Unaudited) Movano Inc.Condensed Consolidated Statements of Stockholders’ Equity (Deficit)(in thousands, except share data)(Unaudited) Movano Inc.Condensed Consolidated Statements of Cash Flows(in thousands)(Unaudited) Movano Inc.Notes to Condensed Consolidated Financial StatementsFor the three and six months ended June 30, 2025 and 2024(Unaudited) NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS Movano Inc., dba Movano Health (the “Company”, “Movano”, “Movano Health”, “we”, “us” or “our”) was incorporated in Delawareon January 30, 2018 as Maestro Sensors Inc. and changed its name to Movano Inc. on August 3, 2018. The Company is a technologycompany and is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to theforefront of consumer health devices. The Company’s solutions provide vital health information, including heart rate, heart rate variability (“HRV”), sleep, respiration rate,temperature, blood oxygen saturation (SpO2), steps, and calories as well as glucose and blood pressure data, in a variety of formfactors to meet individual style needs and give users actionable feedback to improve their quality of life. On April 28, 2021, the Company established Movano Ireland Limited, organized under the laws of Ireland, as a wholly ownedsubsidiary of the Company. Operations and activity at the wholly owned subsidiary were not significant for the three a